Company page
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. is a public company traded under the ticker AVIR in the American market. The company has a market capitalization of approximately $348.9 million. Atea focuses on developing innovative antiviral therapies to address significant unmet medical needs.
- Ticker
- AVIR:NASDAQ
- Asset type
- Stock
- Market cap
- $348.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD